Your browser doesn't support javascript.
loading
Oncogenic Addiction to ERBB2 Signaling Predicts Response to Trastuzumab in Urothelial Cancer.
Karass, Michael; Bareja, Rohan; Shelkey, Ethan; Vlachostergios, Panagiotis J; Robinson, Brian D; Khani, Francesca; Mosquera, Juan Miguel; Scherr, Douglas S; Sboner, Andrea; Tagawa, Scott T; Molina, Ana M; Elemento, Olivier; Nanus, David M; Faltas, Bishoy M.
Afiliação
  • Karass M; Division of Internal Medicine, New York Medical College, Westchester Medical Center, Valhalla, New York.
  • Bareja R; Department of Physiology and Biophysics, and.
  • Shelkey E; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York.
  • Vlachostergios PJ; Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina; and.
  • Robinson BD; Department of Medicine, Division of Hematology and Medical Oncology.
  • Khani F; Department of Pathology and Laboratory Medicine.
  • Mosquera JM; Englander Institute for Precision Medicine.
  • Scherr DS; Department of Pathology and Laboratory Medicine.
  • Sboner A; Department of Pathology and Laboratory Medicine.
  • Tagawa ST; Englander Institute for Precision Medicine.
  • Molina AM; Department of Urology, and.
  • Elemento O; Department of Physiology and Biophysics, and.
  • Nanus DM; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York.
  • Faltas BM; Englander Institute for Precision Medicine.
J Natl Compr Canc Netw ; 17(3): 194-200, 2019 03 01.
Article em En | MEDLINE | ID: mdl-30865916
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Uretrais / Transdução de Sinais / Receptor ErbB-2 / Trastuzumab / Vício Oncogênico / Antineoplásicos Imunológicos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Uretrais / Transdução de Sinais / Receptor ErbB-2 / Trastuzumab / Vício Oncogênico / Antineoplásicos Imunológicos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article